Mater Private Hospital
- Address
- lock Available on a paid plan
Cardiovascular Diseases
The Oncology department at Mater Private Hospital is also exploring heart conditions, concentrating on patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation. The trials seek to evaluate a novel anti‑inflammatory biologic to lower cardiovascular mortality and heart‑failure events.
- Inflammation‑driven heart failure
- Monthly subcutaneous biologic therapy
- Risk reduction of cardiovascular death
- Integration with standard heart‑failure care
With 14 investigators overseeing four active studies, the site in Dublin contributes valuable data on managing heart failure in the European research community.
Neoplasms
The oncology unit at Mater Private Hospital conducts multiple studies on prostate adenocarcinoma and various forms of breast cancer, including early‑stage ER+/HER2‑ disease. These trials aim to test new hormonal agents and targeted therapies that can delay progression, reduce metastasis, and prevent recurrence.
- Castration‑naïve metastatic prostate cancer
- Oral selective androgen receptor inhibitor
- Selective estrogen receptor degraders
- Combination endocrine therapy with CDK4/6 inhibition
Across four trials, 14 investigators are evaluating innovative treatments to improve outcomes for patients with these cancers, reinforcing the site’s role in advancing cancer care in Ireland and Europe.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 3 therapeutic areas and 15 of 56 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 56 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 8 by active trials.
- 1Unicancer3active
lock +7 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Cancer Trials Ireland5trials
lock +4 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 45 other sites in Ireland
Therapeutic Area Benchmark — Ireland
Select a therapeutic area to compare against other sites in Ireland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Ireland
Market Share
Country: Ireland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Mater Private Hospital
lock Showing 1 of 22 trials — the rest is available on a paid plan.
IMP list
lock Showing 1 of 56 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Anastrozole | 5 | Unknown | 2012-04-26 | 2026-04-23 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.